Zinc finger protein 334 (ZNF334) is a member of the zinc finger protein family, a diverse group of proteins that play pivotal roles in DNA binding, RNA binding, and protein-protein interactions. The defining characteristic of zinc finger proteins is their zinc finger motifs-structural domains that coordinate zinc ions to stabilize their folds. These motifs typically consist of a combination of cysteine (C) and histidine (H) residues that bind a zinc ion, hence the C2H2-type zinc finger nomenclature.ZNF334, like its relatives, is characterized by the presence of these C2H2-type zinc finger domains. These domains facilitate the protein's ability to specifically bind DNA, which suggests ZNF334 may act as a transcription factor. Transcription factors are critical in the regulation of gene expression, capable of turning genes on or off in response to various biological signals and conditions. ZNF334, through its interaction with DNA, is likely involved in the transcriptional control of genes crucial for a range of cellular processes.
The precise mechanisms by which ZNF334 influences gene expression and the specific target genes it regulates are areas of ongoing research. Zinc finger proteins can be involved in diverse biological functions, including but not limited to, cell differentiation, growth, development, and apoptosis. Consequently, ZNF334 may be implicated in these or other cellular pathways.Dysfunction or aberrant expression of zinc finger proteins such as ZNF334 can lead to various human diseases, including developmental disorders, cancer, and other genetic diseases. Therefore, understanding the role of ZNF334 in gene regulation and cellular function is important for revealing its contributions to physiology and potential links to pathology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting gene expression patterns and indirectly influencing ZNF334 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase (HDAC) inhibitor, which may alter chromatin structure and gene expression, potentially impacting ZNF334. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDAC inhibitor, potentially affecting gene regulation and indirectly influencing ZNF334 activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, which can alter gene expression and potentially impact ZNF334. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, affects DNA methylation and gene expression, potentially influencing ZNF334. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective HDAC inhibitor, which may have implications for gene regulation involving ZNF334. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor, potentially influencing gene expression and regulatory mechanisms involving ZNF334. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Another BET bromodomain inhibitor, which can affect transcription regulation, potentially impacting ZNF334. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
A G9a/GLP histone methyltransferase inhibitor, potentially altering epigenetic marks and gene expression relevant to ZNF334. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A selective EZH2/EZH1 inhibitor, potentially affecting gene expression patterns relevant to ZNF334. | ||||||